Zenith Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹93 crore and net profit of ₹2.00 crore for the March 2026 quarter.
Zenith Drugs (NSE: ZENITHDRUG-SM) closed at ₹40.00 on 20 Nov 2026, down 31.7% over the past year. Its market capitalisation is ₹69 crore and it trades at 16.7 times earnings.
Incorporated in 2000, Zenith Drugs Ltd is manufacturer of a range of healthcare drugs and allied products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.